Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Desmopressin – Cardiology MCQ – Answer
No Comments | Apr 19, 2020
-
Heart failure with preserved ejection fraction (HFpEF) – Cardiology MCQ
No Comments | Sep 13, 2018
-
Benefit of DOAC over warfarin – Cardiology MCQ – Answer
No Comments | Apr 18, 2020
-
Most commonly monitored ECG lead in cardiac monitors – Cardiology MCQ
No Comments | May 10, 2018
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal